These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 1686300

  • 1. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 2. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A, Yamaguchi T, Kato T.
    Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213
    [Abstract] [Full Text] [Related]

  • 3. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC, Altar CA.
    J Neurochem; 1987 Mar 04; 48(3):824-31. PubMed ID: 2949060
    [Abstract] [Full Text] [Related]

  • 4. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 5. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 6. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 10; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 12. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 10; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 13. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct 10; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 14. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE.
    Neurosci Lett; 1991 Aug 19; 129(2):265-8. PubMed ID: 1720879
    [Abstract] [Full Text] [Related]

  • 15. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G, Ross SB, Kelder D, Edis LE, Jackson DM.
    Pharmacol Toxicol; 1990 Aug 19; 67(2):123-31. PubMed ID: 1979437
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE, Sutherland JV, Woolverton WL.
    Behav Neural Biol; 1990 May 19; 53(3):378-92. PubMed ID: 1972014
    [Abstract] [Full Text] [Related]

  • 17. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL, Crocker AD.
    Neurosci Lett; 1990 Jul 17; 115(1):81-5. PubMed ID: 1977110
    [Abstract] [Full Text] [Related]

  • 18. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 17; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 19. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
    Bertorelli R, Zambelli M, Di Chiara G, Consolo S.
    J Neurochem; 1992 Jul 17; 59(1):353-7. PubMed ID: 1351928
    [Abstract] [Full Text] [Related]

  • 20. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF, Oparil S.
    Brain Res; 1987 Jan 06; 400(2):225-31. PubMed ID: 2949797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.